I have conducted clinical, basic and translational neuroscience research over the past ten years. During this time, in my research for obtaining master (2009-2011) and Ph.D. (2011-2015) degrees I have investigated neuroinflammatory processes associated with behavior, mood and cognitive disorders in animal models of encephalopathy, especially cerebral malaria. I have also investigated potential therapies strategies to prevent neuropsychiatric and cognitive sequelae in this condition. In parallel to the study with animal models, I have been involved in clinical and translational research in the field of neuroimmunology, especially aiming to address potential inflammatory biomarkers for human neuropsychiatric disorders including Parkinson’s Disease and Bipolar Disorder. During my PhD, I have also joined to Dr. Richard Ransohoff laboratory at the Cleveland Clinic during one-year period (2013-2014). At Dr. Ransohoff laboratory, I had the opportunity to broaden my knowledge in the Neuroimmunology field studying the bidirectional interface between the central nervous system and the immune system in different models of human disease including traumatic brain injury. In February 2016, I assumed a position as Associate Professor in the Morphology Department at Federal University of Minas Gerais (UFMG), Brazil. It is worth mentioning, that I was the unique Brazilian investigator to earn the 2016 NARSAD Young Investigator Grant Award from the Brain and Behavior Research Foundation. Recently, in September 21, 2020, I joined as a Postdoctoral Associate in Dr. Prado’s laboratory at Robarts Research Institute in the University of Western Ontario. I studied the role of epichaperomes as potential therapeutic targets to rescue cognitive deficits in mouse models of synucleinopathies. The joint experience of the Prado lab in the neurodegenerative disease field and the availability of Research Cores (such as Rodent Cognition Core for touchscreen technology) provide unique opportunities for my growth as a researcher, including improving my communication skills, and broadening my knowledge base and critical thinking. Importantly, the BrainsCan award recently earned provided a great and unique opportunity to continue interacting with a highly dynamic and versatile group of researchers at Western using cutting-edge technologies to understand synucleinopathies- associated cognitive decline.